About
Inflammation Detection
Areas of Focus
Categories
DiagnosticsBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
3,020
By Phase
PHASE2: 1
By Status
RECRUITING: 1COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
Hover over trial bars to see details
Recent Trials
NCT05423860Lead Sponsor
Phase I Human Analytics (HALO) Study
N/ARecruiting
2,000 participants
Started: Mar 16, 2022 · Completed: Mar 31, 2037
NCT03373006Lead Sponsor
A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer
PHASE2Completed
20 participants
Started: Feb 27, 2018 · Completed: Jan 30, 2020
NCT02243033Lead Sponsor
Phase II Laser Focal Therapy of Prostate Cancer
N/AActive, not recruiting
1,000 participants
Started: May 31, 2016 · Completed: Nov 30, 2036
Locations (1)
Headquarters
Wellesley, MA, United States
Map
Loading map...